OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Novo Nordisk A/S NOVO NORDISK ORD.../  DK0062498333  /

London International
2024-05-24  6:34:50 PM Chg. - Volume Bid9:00:05 AM Ask9:00:05 AM Market Capitalization Dividend Y. P/E Ratio
937.40DKK - 1.26 mill.
Turnover: 91.14 mill.		 731.10Bid Size: 1,000 760.90Ask Size: 1,000 2562.17 bill.DKK 1.26% 39.95
Newsfile Corp 08-28 The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire 08-28 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire 08-28 Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
GlobeNewswire 08-27 COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire 08-26 Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amy...
GlobeNewswire 08-21 ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
GlobeNewswire 08-15 Zealand Pharma Announces Financial Results for the First Half of 2024
GlobeNewswire 08-14 19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire 08-13 COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
GlobeNewswire 08-07 Pattern Announces Company Presentation at LSX World Congress USA
TeleTrader 08-07 Europe higher premarket amid earnings reports
GlobeNewswire 08-07 Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.
GlobeNewswire 08-06 Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire 08-02 Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting A...
GlobeNewswire 08-01 Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024
GlobeNewswire 08-01 Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Dire...
GlobeNewswire 07-31 Icahn School of Medicine at Mount Sinai Launches New Educational Curriculum
GlobeNewswire 07-29 Veru to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire 07-29 SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors
GlobeNewswire 07-16 Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
GlobeNewswire 07-15 Abivax Provides Operational and Key Program Update
GlobeNewswire 07-11 Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansio...
GlobeNewswire 07-11 NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
GlobeNewswire 07-11 NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
GlobeNewswire 07-08 Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into...